Prescribed Health Apps Market Outlook 2027 by Key Players, Industry Trends
Market Overview
The development of the market for prescribed health apps is anticipated to be motivated by the seamless connectivity established between the patients and the healthcare provider. The ease of accessibility to emergency and important medical information is expected to further increase the penetration of the prescribed health apps in the end user base around the globe. The prevalent trend for health monitoring is expected to influence the market progress deeply in the forecast period.
The penetration of technology in healthcare has created a very broad base for the growth of prescribed health apps. Reports that gauge the healthcare IT industry has been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is expected to chart an upward growth trajectory with a favorable CAGR in the impending period.
Read More:https://www.marketresearchfuture.com/reports/prescribed-health-apps-market-753
Segmental Analysis
The segmental evaluation of the prescribed health apps market is conducted on the basis of the operating system, devices, and region. On the basis of the operating system, the prescribed health apps market is segmented into Androids, Windows, and iPhones. Based on the devices, the prescribed health apps market is segmented into multi-parameter tracker, diabetes management device and cardiac monitoring device. On the basis of regions, the prescribed health apps market is segmented into the Middle East, Asia Pacific, Americas, Europe and Africa.
Competitive Analysis
The ease in accessing key planned opportunities important to consequent stabilization of inflation is projected to generate a promising option for development in the approaching years. In the approaching years, the control exerted by fairly high-income level nations around the world and the likely gains observed towards a few of the currencies around the world is projected to strengthen the fruition of the market in the forecast period. A significant climb in the number of backers in the market is expected to craft an advantageous state of affairs for the evolution of the market in the projected period.
The central competitors shaping the prescribed health apps market globally are Apple, iHealth Lab, Inc. BioTelemetry Inc. Sanofi, AirStrip Technologies, Inc, LifeWatch AG among others.
Industry Updates
• Mar 2019 A Seattle-based digital prescribing platform, Xealth, has successfully raised USD 11 million in Series A funding from Novartis, McKesson Ventures, Philips, and ResMed. The existing investors are UPMC and Froedtert, Providence Ventures, Threshold Ventures, and the Medical College of Wisconsin health network which had also participated in the funding round.
• Jan 2019 Otsuka is planning on working together with Click Therapeutics to develop and commercialize a ‘prescription digital therapeutic’ for major depressive disorder (MDD). Otsuka will assign capital to entirely fund the growth of Click’s mobile app ‘CT-152’ for MDD, and to commercialize it globally upon attainment of regulatory approvals